Terms: = Kidney tumors AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
3 results:
1. clinical effects of single nucleotide polymorphisms on drug-related genes in Japanese metastatic renal cell carcinoma patients treated with sunitinib.
Numakura K; Tsuchiya N; Kagaya H; Takahashi M; Tsuruta H; Inoue T; Narita S; Huang M; Satoh S; Niioka T; Miura M; Habuchi T
Anticancer Drugs; 2017 Jan; 28(1):97-103. PubMed ID: 27564227
[TBL] [Abstract] [Full Text] [Related]
2. Biomarker discovery in urogenital cancer.
Said J
Biomarkers; 2005 Nov; 10 Suppl 1():S83-6. PubMed ID: 16298916
[TBL] [Abstract] [Full Text] [Related]
3. Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma.
Aklilu M; Stadler WM; Markiewicz M; Vogelzang NJ; Mahowald M; Johnson M; Gajewski TF
Ann Oncol; 2004 Jul; 15(7):1109-14. PubMed ID: 15205206
[TBL] [Abstract] [Full Text] [Related]
